project id: TCGA-HNSC; case submitter id: TCGA-4P-AA8J; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.79; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.5; rna integrity number: 8.3; age at index: 66; days to birth: -24222; ethnicity: not hispanic or latino; gender: male; race: black or african american; vital status: Alive; year of birth: 1947; age at diagnosis: 24222; ajcc clinical m: M0; ajcc clinical n: N2a; ajcc clinical stage: Stage IVA; ajcc clinical t: T4a; ajcc pathologic m: MX; ajcc pathologic n: N2c; ajcc pathologic stage: Stage IVA; ajcc pathologic t: T2; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 102.0; icd 10 code: C02.9; last known disease status: not reported; morphology: 8071/3; primary diagnosis: Squamous cell carcinoma, keratinizing, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Tongue, NOS; synchronous malignancy: No; tissue or organ of origin: Tongue, NOS; tumor grade: Not Reported; year of diagnosis: 2013; treatment or therapy: no; alcohol history: No; is ffpe: false; composition: Not Reported; days to collection: 120; days to sample procurement: 0; initial weight: 90.0; portion submitter id: TCGA-4P-AA8J-01A-11; percent lymphocyte infiltration: 10.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 40.0; percent tumor cells: 60.0; percent tumor nuclei: 70.0;